“The intersection of SARS-CoV-2 and Lung Cancer”

The Pamela Hearn Isom Lectureship in Honor of Eugene P. Frenkel, M.D.

Speaker:

Philip Mack, Ph.D.
Professor of Medicine
Hematology and Medical Oncology
Associate Director, Center for Thoracic Oncology
Mount Sinai Health System

About Philip Mack:

Dr. Mack holds a Bachelor's degree in biochemistry and molecular biology from University of California, Santa Cruz. He also earned a Dcctorate in molecular biology and genetics from University of California, Davis.

Dr. Mack conducts molecular biology, molecular pharmacology studies and translational medicine associated with cancer clinical trials, with a focus on lung cancer.

He specializes in preclinical modeling of novel cancer therapeutic regimens, clinical trial development, and helped pioneer the concept of detecting circulating tumor DNA in patient plasma as an advanced diagnostic to enable precision medicine in oncology. He has over 140 peer-reviewed publications in oncology. A recent focus has been the intersection between COVID-19 and lung cancer.